Appointments at AAIPharma, AMRI and Icon – People on the move
AAIPharma Services has promoted Dan Shirazi to vice president (VP), analytical development. Shirazi joined AAIPharma as a senior scientist in 1992 and has since been promoted a number of times.
Peter Hansbury has joined AMRI as VP of aseptic services. The position gives Hansbury leadership of the aseptic fill and finish facility in Burlington, Massachusetts. In his 30 years working in sterile products Hansbury has held positions Ben Venue Laboratories and LyphoMed.
Icon has strengthened its medical imaging unit by promoting Kornelia Martin to VP, European operations. Martin joined the medical imaging unit at Icon in January 2009 having previously worked at Focus Clinical Drug Development, Synarc and Baxter.
Also, Icon has made two appointments to boost its Asia Pacific team. Malcolm Burgess has been named EVP, Asia Pacific, and Paula Mumby has been hired as VP, operations, Asia Pacific for the resourcing business unit at Icon.
Burgess joined Icon in 2002 after a career spent at Novartis, Hoechst Marion Roussel and SmithKline Beecham. Mumby has previously worked at i3 Pharma Resourcing and CSL.
Dennis Schmatz has joined Scynexis as a strategic advisor for anti-infectives. Scynexis is developing an internal pipeline and provides contract research services. Schmatz last worked as CEO of non-profit Medicines for Malaria Venture
Asymchem Life Science has hired Robert Andrews as VP of quality assurance. Andrews has 18 years of pharmaceutical experience from working at Banner Pharmacaps, TSI Health Services and Pridecraft Enterprises.
David Neu has been promoted to the position of president of AmerisourceBergen Drug Corporation. Neu succeeds Steven Collis who will become CEO following the retirement of David Yost on July 1 2011.
